Tong SYC, et al. Staphylococcus aureus Infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Investig. 2003;111(9):1265–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spellberg B, Daum R. Development of a vaccine against Staphylococcus aureus. Seminars in Immunopathology. 2012;34(2):335–48.

Article  CAS  PubMed  Google Scholar 

Jansen KU, et al. Vaccine review: “Staphyloccocus aureus vaccines: problems and prospects.” Vaccine. 2013;31(25):2723–30.

Article  CAS  PubMed  Google Scholar 

Giersing BK, et al. Status of vaccine research and development of vaccines for Staphylococcus aureus. Vaccine. 2016;34(26):2962–6.

Article  CAS  PubMed  Google Scholar 

Vahdani Y, et al. Molecular cloning and immunogenicity evaluation of IsdE protein of methicillin resistant Staphylococcus aureus as vaccine candidates. Microb Pathog. 2021;157: 104953.

Article  CAS  PubMed  Google Scholar 

Proctor RA. Is there a future for a Staphylococcus aureus vaccine? Vaccine. 2012;30(19):2921–7.

Article  CAS  PubMed  Google Scholar 

McConnell MJ, Pachón J. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. Vaccine. 2010;29(1):1–5.

Article  CAS  PubMed  Google Scholar 

van Diemen PM, et al. Irradiated wild-type and Spa mutant Staphylococcus aureus induce anti- S. aureus immune responses in mice which do not protect against subsequent intravenous challenge. Pathog Dis. 2013;68(1):20–26.

Zhang F, et al. Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine. Vaccine. 2017;35(31):3834–43.

Article  CAS  PubMed  Google Scholar 

Burnside K, et al. Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection. J Infect Dis. 2012;206(11):1734–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim HK, et al. Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses. FASEB J. 2011;25(10):3605–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pereira UP, et al. Efficacy of Staphylococcus aureus vaccines for bovine mastitis: a systematic review. Vet Microbiol. 2011;148(2):117–24.

Article  CAS  PubMed  Google Scholar 

Camussone CM, et al. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant. Vet Immunol Immunopathol. 2014;162(3):96–107.

Article  CAS  PubMed  Google Scholar 

Camussone CM, et al. Immune response of heifers against a Staphylococcus aureus CP5 whole cell and lysate vaccine formulated with ISCOM Matrix adjuvant. Res Vet Sci. 2014;96(1):86–94.

Article  CAS  PubMed  Google Scholar 

Badr AA, et al. Efficacy of lysigin vaccine in the prevention of mastitis in dairy cattle. Vet Med J (Giza). 2023;69(1):56–68.

Google Scholar 

Middleton JR, et al. Efficacy of different Lysigin™ formulations in the prevention of Staphylococcus aureus intramammary infection in dairy heifers. J Dairy Res. 2006;73(1):10–9.

Article  CAS  PubMed  Google Scholar 

Habibi M, Asadi Karam MR, Bouzari S. Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model. Int Immunopharmacol. 2015;28(1):70–78.

Eshraghi Y, et al. Immunomodulatory effects of α-tocopherol on the H1N1 influenza vaccine: improving the potency and efficacy of the influenza vaccine in aged mice. Viral Immunol. 2022;35(3):244–53.

Article  CAS  PubMed  Google Scholar 

Sepasi A, et al. Formulation of recombinant H1N1 hemagglutinin in MF59 and alum adjuvants: a comparison of the vaccines potency and efficacy in BALB/C mice. Viral Immunol. 2023;36(6):401–8.

Article  CAS  PubMed  Google Scholar 

Savoji MA, et al. Formulation of HBs antigen in Montanide ISA266 shows superiority to commercial HBsAg vaccine in the induction of humoral immune responses. Gastroenterol Hepatol Bed Bench. 2019;12(4):292–300.

PubMed  PubMed Central  Google Scholar 

Roohvand F, et al. HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses. Biochem Biophys Res Commun. 2007;354(3):641–9.

Article  CAS  PubMed  Google Scholar 

Shokri M, et al. Comparing Montanide ISA 720 and 50–V2 adjuvants formulated with LmSTI1 protein of Leishmania major indicated the potential cytokine patterns for induction of protective immune responses in BALB/c mice. Mol Immunol. 2016;76:108–15.

Article  CAS  PubMed  Google Scholar 

Haghighat S, et al. Cloning, expression and purification of autolysin from methicillin-resistant Staphylococcus aureus: potency and challenge study in Balb/c mice. Mol Immunol. 2017;82:10–8.

Article  CAS  PubMed  Google Scholar 

Dehnavi M, et al. Glucomannan as a polysaccharide adjuvant improved immune responses against Staphylococcus aureus: potency and efficacy studies. Microb Pathog. 2023;176: 106007.

Article  CAS  PubMed  Google Scholar 

Ranjbariyan A, et al. Synthetic selenium nanoparticles as co-adjuvant improved immune responses against methicillin-resistant Staphylococcus aureus. World J Microbiol Biotechnol. 2022;39(1):16.

Article  PubMed  PubMed Central  Google Scholar 

Mirshekar M, et al. Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection. Immunol Res. 2024;72(3):490–502.

Article  CAS  PubMed  Google Scholar 

Clegg J, et al. Staphylococcus aureus vaccine research and development: the past, present and future, including novel therapeutic strategies. Front Immunol. 2021;12:705360–705360.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ansari S, et al. Recent advances in Staphylococcus aureus infection: focus on vaccine development. Infect Drug Resist. 2019;12:1243–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Diemen PM, et al. Irradiated wild-type and Spa mutant Staphylococcus aureus induce anti-S. aureus immune responses in mice which do not protect against subsequent intravenous challenge. Pathog Dis. 2013;68(1):20–6.

Moscoso M, et al. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus. Virulence. 2018;9(1):604–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia-Romo GS, et al. Immunization with heat-inactivated Staphylococcus aureus induced an antibody response mediated by IgG1 and IgG2 in patients with recurrent tonsillitis. Microbiol Immunol. 2015;59(4):193–201.

Article  CAS  PubMed  Google Scholar 

Cunningham AL, et al. Vaccine development: from concept to early clinical testing. Vaccine. 2016;34(52):6655–64.

Article  CAS  PubMed  Google Scholar 

Luby CD, Middleton JR, Jianneng M, Rinehart CL, Bucklin S, Kohler C, Tyler JW. Characterization of the antibody isotype response in serum and milk of heifers vaccinated with a Staphylococcus aureus bacterin (Lysigin). J Dairy Res. 2007;74: 239–46.

Rezaei A, et al. Adjuvant effects of pseudomonas aeruginosa flagellin on the immunological patterns of the HIV-1 vaccine candidate: vaccine formulations versus different